AGP Executive Report
Last update: 9 hours agoPancreatic cancer breakthrough: A new daily pill, daraxonrasib, nearly doubled survival for people with advanced metastatic pancreatic cancer in a major trial, with a median 13.2 months vs 6.7 months on chemotherapy—an early sign of a major shift in treatment. Cancer care in Arizona: University of Arizona Cancer Center specialist Rachna Shroff highlighted the “durable and meaningful” benefit after ASCO results, underscoring why this matters locally for patients and clinicians. Oral health and pregnancy: A Scottsdale-area discussion stressed that gum disease can raise risk for pre-eclampsia, pushing dental care to be treated as part of maternal health—not separate. Opioids at work: Valley Leadership’s opioid use disorder business toolkit is expanding with Maricopa County support, aiming to help hospitality and construction employers respond to substance use and protect workers. Nursing home watch: CMS data shows Sandstone Estates Rehab Centre in Tucson earned a 2-star rating in early 2026, adding to ongoing attention on staffing and care quality. Local health access: EVIT’s transportation fight with East Valley districts could disrupt students’ ability to reach career/technical education classes.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
